Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study
暂无分享,去创建一个
S. Solomon | I. Piña | G. Felker | J. Butler | J. Contreras | J. Januzzi | A. Omar | Jonathan H. Ward | Sean Murphy | Yuxi Liu
[1] S. Solomon,et al. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. , 2019, JAMA.
[2] S. Yun,et al. Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: PRIME Study , 2019, Circulation.
[3] R. Levine,et al. Evolution of secondary mitral regurgitation , 2018, European heart journal cardiovascular Imaging.
[4] Yuchi Han,et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[5] P. Voisine,et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. , 2019, The New England journal of medicine.